254 related articles for article (PubMed ID: 26933820)
1. The matricellular protein CCN6 (WISP3) decreases Notch1 and suppresses breast cancer initiating cells.
Huang W; Martin EE; Burman B; Gonzalez ME; Kleer CG
Oncotarget; 2016 May; 7(18):25180-93. PubMed ID: 26933820
[TBL] [Abstract][Full Text] [Related]
2. CCN6 modulates BMP signaling via the Smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer.
Pal A; Huang W; Li X; Toy KA; Nikolovska-Coleska Z; Kleer CG
Cancer Res; 2012 Sep; 72(18):4818-28. PubMed ID: 22805309
[TBL] [Abstract][Full Text] [Related]
3. CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer.
Kleer CG; Zhang Y; Merajver SD
Cells Tissues Organs; 2007; 185(1-3):95-9. PubMed ID: 17587813
[TBL] [Abstract][Full Text] [Related]
4. CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer.
Lorenzatti G; Huang W; Pal A; Cabanillas AM; Kleer CG
J Cell Sci; 2011 May; 124(Pt 10):1752-8. PubMed ID: 21525039
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells.
Zhang Y; Pan Q; Zhong H; Merajver SD; Kleer CG
Breast Cancer Res; 2005; 7(6):R1080-9. PubMed ID: 16457688
[TBL] [Abstract][Full Text] [Related]
6. Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas.
Tran MN; Kleer CG
J Cell Commun Signal; 2018 Mar; 12(1):13-19. PubMed ID: 29357008
[TBL] [Abstract][Full Text] [Related]
7. MMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas.
Martin EE; Huang W; Anwar T; Arellano-Garcia C; Burman B; Guan JL; Gonzalez ME; Kleer CG
Oncogene; 2017 Apr; 36(16):2275-2285. PubMed ID: 27819674
[TBL] [Abstract][Full Text] [Related]
8. Blockade of CCN6 (WISP3) activates growth factor-independent survival and resistance to anoikis in human mammary epithelial cells.
Huang W; Gonzalez ME; Toy KA; Banerjee M; Kleer CG
Cancer Res; 2010 Apr; 70(8):3340-50. PubMed ID: 20395207
[TBL] [Abstract][Full Text] [Related]
9. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
10. CCN6 regulates IGF2BP2 and HMGA2 signaling in metaplastic carcinomas of the breast.
McMullen ER; Gonzalez ME; Skala SL; Tran M; Thomas D; Djomehri SI; Burman B; Kidwell KM; Kleer CG
Breast Cancer Res Treat; 2018 Dec; 172(3):577-586. PubMed ID: 30220054
[TBL] [Abstract][Full Text] [Related]
11. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
Fang F; Zhao WY; Li RK; Yang XM; Li J; Ao JP; Jiang SH; Kong FZ; Tu L; Zhuang C; Qin WX; He P; Zhang WM; Cao H; Zhang ZG
Int J Clin Exp Pathol; 2014; 7(10):6447-61. PubMed ID: 25400723
[TBL] [Abstract][Full Text] [Related]
12. CCN6 knockdown disrupts acinar organization of breast cells in three-dimensional cultures through up-regulation of type III TGF-β receptor.
Pal A; Huang W; Toy KA; Kleer CG
Neoplasia; 2012 Nov; 14(11):1067-74. PubMed ID: 23226100
[TBL] [Abstract][Full Text] [Related]
13. 3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway.
Chen J; Chang H; Peng X; Gu Y; Yi L; Zhang Q; Zhu J; Mi M
Sci Rep; 2016 Jun; 6():28858. PubMed ID: 27345219
[TBL] [Abstract][Full Text] [Related]
14. Hydrodynamic shear stress promotes epithelial-mesenchymal transition by downregulating ERK and GSK3β activities.
Choi HY; Yang GM; Dayem AA; Saha SK; Kim K; Yoo Y; Hong K; Kim JH; Yee C; Lee KM; Cho SG
Breast Cancer Res; 2019 Jan; 21(1):6. PubMed ID: 30651129
[TBL] [Abstract][Full Text] [Related]
15. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
[TBL] [Abstract][Full Text] [Related]
16. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
[TBL] [Abstract][Full Text] [Related]
17. WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.
Kleer CG; Zhang Y; Pan Q; Merajver SD
Neoplasia; 2004; 6(2):179-85. PubMed ID: 15140407
[TBL] [Abstract][Full Text] [Related]
18. On how CCN6 suppresses breast cancer growth and invasion.
Huang W; Pal A; Kleer CG
J Cell Commun Signal; 2012 Mar; 6(1):5-10. PubMed ID: 21842227
[TBL] [Abstract][Full Text] [Related]
19. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.
Wang N; Liu W; Zheng Y; Wang S; Yang B; Li M; Song J; Zhang F; Zhang X; Wang Q; Wang Z
Cell Death Dis; 2018 Aug; 9(9):880. PubMed ID: 30158589
[TBL] [Abstract][Full Text] [Related]
20. CCN6 enhances ICAM-1 expression and cell motility in human chondrosarcoma cells.
Fong YC; Lin CY; Su YC; Chen WC; Tsai FJ; Tsai CH; Huang CY; Tang CH
J Cell Physiol; 2012 Jan; 227(1):223-32. PubMed ID: 21391218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
